This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
The centerpiece of Bristol Myers Squibb’s $13 billion MyoKardia acquisition fail...
What You Should Know: – Merck Manuals, an independent medical reference resourc...
What You Should Know: – Healthcare providers who received emergency loans from ...
AbbVie and Sandoz have resolved their patent dispute over AbbVie’s blockbuster i...
A panel of experts who decide the national immunization schedule will meet on Tu...
Antibody-drug conjugates startup Duality Biologics will join the public markets ...
The G7 continuous glucose monitoring system will have a 15.5-day wear time and l...
Large language models (LLMs) like ChatGPT and other general-purpose artificial i...
The American Medical Association is urging Optum, a unit of UnitedHealth Group, ...
A union that represents more than 11,000 FDA employees nationwide — the National...
Two new memos update federal AI policy, which the White House says will accelera...
Amgen has enjoyed a monopoly on its blockbuster inflammatory disease drug Enbrel...
On Monday, Pfizer announced it had given up on danuglipron, the company's closel...
Pfizer said a patient dosed with danuglipron developed potential drug-induced li...
For the 164th episode of the Healthcare IT Today Podcast, we are talking about 2...
The government is fighting in court for a plan to cut spending on overhead resea...